COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1845: Articles 18441-18450  | Next

Persistently increased systemic ACE2 activity and Furin levels are associated with increased inflammatory response in smokers with SARS-CoV-2 COVID-19
Kaur, G., Yogeswaran, S., Muthumalage, T., Rahman, I.
10.1101/2021.01.14.21249836 — Posted: 2021-01-15
The Use of Procalcitonin as an Antimicrobial Stewardship Tool and a Predictor of Disease Severity in COVID-19
Drewett, G. P., Smibert, O. C., Holmes, N. E., Trubiano, J. A.
10.1101/2021.01.14.21249853 — Posted: 2021-01-15
Optimising SARS-CoV-2 pooled testing strategies on social networks for low-resource settings
Mazzitello, K. I., Jiang, Y., Arizmendi, C. M.
10.1101/2021.01.13.20249064 — Posted: 2021-01-15
The impact of high dose oral cotrimoxazole in patients with COVID-19 with hypoxic respiratory failure requiring non-invasive ventilation: A Case Control Study
Singh, S., John, T., Kumar, P., Quadery, S. R.
10.1101/2021.01.14.21249803 — Posted: 2021-01-15
Detection of SARS-Cov-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.
Rodriguez Serrano, D. A., Roy-Vallejo, E., Zurita Cruz, N. D., Martin Ramirez, A., Rodriguez-Garcia, S. C., Arevalillo-Fernandez, N., Galvan-Roman, J. M., Fontan Garcia-Rodrigo, L., Vega Piris, L., Chicot Llano, M., Arribas Mendez, D., Gonzalez de Marcos, B., Hernando Santos, J., Sanchez Azofra, A., Avalos Perez-Urria, E., Rodriguez-Cortes, P., Esparcia, L., Marcos-Jimenez, A., Sanchez-Alonso, S., Llorente, I., Soriano, J. B., Suarez Fernandez, C., Garcia-Vicuna, R., Ancochea, J., Sanz, J., Munoz-Calleja, C., de la Camara, R., Canabal Berlanga, A., Gonzalez-Alvaro, I., Cardenoso, L.
10.1101/2021.01.14.21249372 — Posted: 2021-01-15
Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection
Silverstein, N. J., Wang, Y., Manickas-Hill, Z., Carbone, C. C., Dauphin, A., Li, J. Z., Walker, B. D., Yu, X. G., Luban, J.
10.1101/2021.01.14.21249839 — Posted: 2021-01-15
A Vital Sign-based Prediction Algorithm for Differentiating COVID-19 Versus Seasonal Influenza in Hospitalized Patients
Yanamala, N., Krishna, N. H., Hathaway, Q. A., Radhakrishnan, A., Sunkara, S., Patel, H., Farjo, P., Patel, B., Sengupta, P. P.
10.1101/2021.01.13.21249540 — Posted: 2021-01-15
Anticipating the curve: can online symptom-based data reflect COVID-19 case activity in Ontario, Canada?
Maharaj, A. S., Parker, J., Hopkins, J. P., Gournis, E., Bogoch, I., Rader, B., Astley, C. M., Ivers, N. M., Hawkins, J. B., Lee, L., Tuite, A., Fisman, D. N., Brownstein, J. S., Lapointe-Shaw, L.
10.1101/2021.01.15.21249879 — Posted: 2021-01-15
Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19
Wang, J., Kotagiri, P., Lyons, P., Mescia, F., Bergamaschi, L., Turner, L., Al-Lamki, R., Morgan, M. D., Calero-Nieto, F. J., Bach, K., Mende, N., Wilson, N. K., Watts, E. R., Cambridge Institute of Therapeutic Immunology and Infectious Disease - NIHR Covid BioResource, , Chinnery, P., Kingston, N., Papadia, S., Stirrups, K., Walker, N., Gupta, R. K., Toshner, M., Weekes, M., Nathan, J. A., Walmsley, S., Ouwehand, W. H., Kasanicki, M., Gottgens, B., Marioni, J. C., Smith, S. G., Pober, J. S., Bradley, J. R.
10.1101/2021.01.14.21249801 — Posted: 2021-01-15
Antibiotic Prescribing Patterns at COVID-19 Dedicated Wards in Bangladesh: A Single Center Point-Prevalence Survey
Molla, M. M. A., Yeasmin, M., Islam, M. K., Sharif, M. M., Amin, M. R., Nafisa, T., Ghosh, A. K., Parveen, M., Arif, M. M. H., Alam, J. A. J., Rizvi, S. J. R., Saif-Ur-Rahman, K., Akram, A., Shamsuzzaman, A.
10.1101/2021.01.15.21249868 — Posted: 2021-01-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).